{
    "organizations": [],
    "uuid": "1ac6b96d98e23f3f2b54014a83c90ba601036d13",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-baytacare-pharmaceutical-co-says-w/brief-baytacare-pharmaceutical-co-says-wang-shaoyan-removed-as-chairman-idUSFWN1S70MX",
    "ord_in_thread": 0,
    "title": "BRIEF-Baytacare Pharmaceutical Co Says Wang Shaoyan Removed As Chairman",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 30 (Reuters) - Baytacare Pharmaceutical Co Ltd :\n* SUSPEND ROLES AND DUTIES OF WANG AS AN EXECUTIVE DIRECTOR WITH IMMEDIATE EFFECT\n* SAYS REMOVES WANG SHAOYAN AS CHAIRMAN; FORMS SPECIAL INVESTIGATION COMMITTEE\n* ANNOUNCES REMOVAL OF WANG SHAOYAN AS CHAIRMAN OF BOARD Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-30T18:36:00.000+03:00",
    "crawled": "2018-05-01T19:53:13.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "baytacare",
        "pharmaceutical",
        "co",
        "ltd",
        "suspend",
        "role",
        "duty",
        "wang",
        "executive",
        "director",
        "immediate",
        "effect",
        "say",
        "remove",
        "wang",
        "shaoyan",
        "chairman",
        "form",
        "special",
        "investigation",
        "committee",
        "announces",
        "removal",
        "wang",
        "shaoyan",
        "chairman",
        "board",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}